DJIA 15,383.88 48.60 0.32%
NASDAQ 3,499.97 3.54 0.10%
S&P 500 1,669.63 3.34 0.20%

264.63 0.99 (0.38%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

REGN $264.63 0.38%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $265.79
Previous Close $263.64
Daily Range $263.49 - $269.78
52-Week Range $107.31 - $283.99
Market Cap $25.9B
P/E Ratio 35.41
Dividend (Yield) $0.00 (0.0%)
Volume 536,285
Average Daily Volume 1,638,328
Current FY EPS $3.60

Sector

Healthcare

Industry

Drugs

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regn.com/

News & Commentary

Regeneron Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-20-2013 10:00 AM

5 Stocks Underperforming Today In The Drugs Industry

Regeneron Pharmaceuticals Inc. Stock Buy Recommendation Reiterated (REGN)

2 Healthcare Companies And 1 Consumer Goods Company With Recent Intensive Insider Selling

Will ASCO Unlock Big Value in This Cancer Drug Class?

With the American Society of Clinical Oncology's annual meeting less than two weeks away, see what drug class could see big gains in the wake of new abstract data.

S&P 500 Stocks Farthest Above 50-DMAs

Sanofi and Regeneron's Latest Partnership

Late-stage clinical trials begin for this duo's experimental rheumatoid arthritis drug.

Sanofi/REGN Commence Enrollment - Analyst Blog

Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Drugs Laggard

3 Stocks Underperforming Today In The Drugs Industry

See More REGN News...

REGN's Top Competitors

REGN $264.63 (0.38%)
Current stock: REGN
AMGN $103.50 (1.29%)
Current stock: AMGN
GILD $56.20 (0.83%)
Current stock: GILD
BIIB $229.64 (1.98%)
Current stock: BIIB